Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Mahidol University's Institutional Repository (Mahidol IR)
Simple jQuery Dropdowns
About Us
Ethics
Service
Statistics & Reports
Feedback
Browsing by Author Thanyanan Reungwetwattana
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 20 of 22
next >
Issue Date
Title
Author(s)
3-Aug-2019
Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
Anne Julienne Genuino
;
Usa Chaikledkaew
;
Due Ong The
;
Thanyanan Reungwetwattana
;
Ammarin Thakkinstian
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Mahidol University
1-May-2019
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
Caicun Zhou
;
Sang We Kim
;
Thanyanan Reungwetwattana
;
Jianying Zhou
;
Yiping Zhang
;
Jianxing He
;
Jin Ji Yang
;
Ying Cheng
;
Se Hoon Lee
;
Lilian Bu
;
Tingting Xu
;
Li Yang
;
Chao Wang
;
Ting Liu
;
Peter N. Morcos
;
You Lu
;
Li Zhang
;
Sun Yat-Sen University Cancer Center
;
Tongji University
;
Zhejiang Cancer Hospital
;
West China School of Medicine/West China Hospital of Sichuan University
;
Guangdong General Hospital
;
Asan Medical Center
;
SungKyunKwan University, School of Medicine
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Guangzhou Medical University
;
F. Hoffmann-La Roche AG
;
Zhejiang University
;
Roche Innovation Center
;
Jilin Cancer Hospital
;
Roche Pharma Development
2016
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
Pimpin Incharoen
;
Thanyanan Reungwetwattana
;
Sakditad Saowapa
;
Kaettipong Kamprerasart
;
Duangjai Pangpunyakulchai
;
Lalida Arsa
;
Artit Jinawath
;
Mahidol University. Faculty of Medicine Ramathibodi Hospital. Department of Pathology
1-Mar-2020
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC
Wan Ling Tan
;
Kevin L.M. Chua
;
Chia Chi Lin
;
Victor H.F. Lee
;
Lye Mun Tho
;
Anthony W. Chan
;
Gwo Fuang Ho
;
Thanyanan Reungwetwattana
;
James C. Yang
;
Dong Wan Kim
;
Ross A. Soo
;
Yong Chan Ahn
;
Hiroshi Onishi
;
Myung Ju Ahn
;
Tony S.K. Mok
;
Daniel S.W. Tan
;
Fan Yang
;
Peking University People's Hospital
;
National Taiwan University Hospital
;
National Cancer Centre, Singapore
;
National University Hospital, Singapore
;
Seoul National University Hospital
;
SungKyunKwan University, School of Medicine
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
University of Malaya Medical Centre
;
University of Yamanashi
;
The University of Hong Kong
;
Chinese University of Hong Kong
;
Beacon Hospital
1-Jan-2020
Association of histologic subtypes with genetic alteration and pd-l1 expression in pulmonary adenocarcinoma
Bantita Phruttinarakorn
;
Thanyanan Reungwetwattana
;
Pimpin Incharoen
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
22-Apr-2011
Chemotherapy for non-small-cell lung carcinoma: From a blanket approach to individual therapy
Thanyanan Reungwetwattana
;
Matthew J. Eadens
;
Julian R. Molina
;
Mahidol University
;
Mayo Medical School
20-Nov-2018
CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer
Thanyanan Reungwetwattana
;
Kazuhiko Nakagawa
;
Byoung Chul Cho
;
Manuel Cobo
;
Eun Kyung Cho
;
Alessandro Bertolini
;
Sabine Bohnet
;
Caicun Zhou
;
Ki Hyeong Lee
;
Naoyuki Nogami
;
Isamu Okamoto
;
Natasha Leighl
;
Rachel Hodge
;
Astrid McKeown
;
Andrew P. Brown
;
Yuri Rukazenkov
;
Suresh S. Ramalingam
;
Johan Vansteenkiste
;
Yonsei Cancer Center
;
Chungbuk National University Hospital
;
Gachon University
;
Tongji University
;
KU Leuven– University Hospital Leuven
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Universitätsklinikum Schleswig-Holstein Campus Lübeck
;
National Hospital Organization, Japan
;
Hospital Regional Universitario Carlos Haya
;
Kyushu University
;
Ontario Cancer Institute University of Toronto
;
AstraZeneca
;
Emory University School of Medicine
;
Kindai University
;
Hospital of Sondrio
21-Nov-2019
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
Anne Julienne Genuino
;
Usa Chaikledkaew
;
Anna Melissa Guerrero
;
Thanyanan Reungwetwattana
;
Ammarin Thakkinstian
;
Department of Health Manila
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Mahidol University
1-Jan-2011
Current and emerging therapies in peripheral T-cell lymphoma: Focus on pralatrexate
Thanyanan Reungwetwattana
;
Sylvia Jaramillo
;
Julian R. Molina
;
Mayo Medical School
;
Mahidol University
1-Jan-2018
Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients
Chalirmporn Atasilp
;
Pichai Chansriwong
;
Ekapob Sirachainan
;
Thanyanan Reungwetwattana
;
Apichaya Puangpetch
;
Santirhat Prommas
;
Suwannee Sirilerttrakul
;
Budsaba Rerkarmnuaychoke
;
Sansanee Wongwaisayawan
;
Chonlaphat Sukasem
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
1-Jan-2020
Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment
Anne Julienne Genuino
;
Mac Ardy Junio Gloria
;
Usa Chaikledkaew
;
Thanyanan Reungwetwattana
;
Ammarin Thakkinstian
;
University of the Philippines Manila
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Mahidol University
1-Dec-2020
Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
Chalirmporn Atasilp
;
Phichai Chansriwong
;
Ekaphop Sirachainan
;
Thanyanan Reungwetwattana
;
Suwannee Sirilerttrakul
;
Monpat Chamnanphon
;
Apichaya Puangpetch
;
Chonlaphat Sukasem
;
Chulalongkorn University
;
Rangsit University
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
1-Jan-2020
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC
Viola W. Zhu
;
Yen Ting Lin
;
Dong Wan Kim
;
Herbert H. Loong
;
Misako Nagasaka
;
Hao To
;
Yvonne Li En Ang
;
Chan Young Ock
;
Nishan Tchekmedyian
;
Sai Hong Ignatius Ou
;
Nicholas L. Syn
;
Thanyanan Reungwetwattana
;
Chia Chi Lin
;
Ross A. Soo
;
National Taiwan University Hospital
;
Yong Loo Lin School of Medicine
;
National Taiwan University College of Medicine
;
Seoul National University Hospital
;
Wayne State University School of Medicine
;
National University of Singapore
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
UCI School of Medicine
;
University of Nevada School of Medicine
;
Chinese University of Hong Kong
;
Pacific Shores Medical Group
1-Nov-2020
Lung Cancer in Thailand
Thanyanan Reungwetwattana
;
Songporn Oranratnachai
;
Putipun Puataweepong
;
Viratch Tangsujaritvijit
;
Piya Cherntanomwong
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
1-Jan-2015
MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approval
Thanyanan Reungwetwattana
;
Sai Hong Ignatius Ou
;
Mahidol University
;
UCI School of Medicine
1-Jul-2012
Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)
Thanyanan Reungwetwattana
;
Saravut J. Weroha
;
Julian R. Molina
;
Mahidol University
;
Mayo Clinic
2-Jan-2020
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
Suresh S. Ramalingam
;
Johan Vansteenkiste
;
David Planchard
;
Byoung Chul Cho
;
Jhanelle E. Gray
;
Yuichiro Ohe
;
Caicun Zhou
;
Thanyanan Reungwetwattana
;
Ying Cheng
;
Busyamas Chewaskulyong
;
Riyaz Shah
;
Manuel Cobo
;
Ki Hyeong Lee
;
Parneet Cheema
;
Marcello Tiseo
;
Thomas John
;
Meng Chih Lin
;
Fumio Imamura
;
Takayasu Kurata
;
Alexander Todd
;
Rachel Hodge
;
Matilde Saggese
;
Yuri Rukazenkov
;
Jean Charles Soria
;
Yonsei Cancer Center
;
Jilin Provincial Cancer Hospital
;
Shanghai Pulmonary Hospital
;
Chang Gung University College of Medicine
;
KU Leuven– University Hospital Leuven
;
Institut de Cancerologie Gustave Roussy
;
Kansai Medical University
;
Université Paris-Sud
;
National Cancer Center Hospital
;
University of Toronto
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Hospital Regional Universitario Carlos Haya
;
Università degli Studi di Parma, Facoltà di Medicina e Chirurgia
;
Chungbuk National University, College of Medicine
;
Austin Health
;
Moffitt Cancer Center
;
Maidstone Hospital
;
AstraZeneca
;
Emory University School of Medicine
;
Chiang Mai University
;
Osaka International Cancer Institute
1-Jan-2015
A phase i study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors
Nuttapong Ngamphaiboon
;
Grace K. Dy
;
Wen Wee Ma
;
Yujie Zhao
;
Thanyanan Reungwetwattana
;
Dawn Depaolo
;
Yi Ding
;
William Brady
;
Gerald Fetterly
;
Alex A. Adjei
;
Roswell Park Cancer Institute
;
Mahidol University
20-Jan-2018
Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinoma
Milind Javle
;
Maeve Lowery
;
Rachna T. Shroff
;
Karl Heinz Weiss
;
Christoph Springfeld
;
Mitesh J. Borad
;
Ramesh K. Ramanathan
;
Lipika Goyal
;
Saeed Sadeghi
;
Teresa Macarulla
;
Anthony El-Khoueiry
;
Robin Kate Kelley
;
Ivan Borbath
;
Su Pin Choo
;
Do Youn Oh
;
Philip A. Philip
;
Li Tzong Chen
;
Thanyanan Reungwetwattana
;
Eric Van Cutsem
;
Kun Huei Yeh
;
Kristen Ciombor
;
Richard S. Finn
;
Anuradha Patel
;
Suman Sen
;
Dale Porter
;
Randi Isaacs
;
Andrew X. Zhu
;
Ghassan K. Abou-Alfa
;
Tanios Bekaii-Saab
;
National Cheng Kung University Hospital
;
Barbara Ann Karmanos Cancer Institute
;
National Cancer Centre, Singapore
;
KU Leuven– University Hospital Leuven
;
UCSF Helen Diller Family Comprehensive Cancer Center
;
Mayo Clinic Scottsdale-Phoenix, Arizona
;
National Taiwan University College of Medicine
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
Keck School of Medicine of USC
;
University of Texas MD Anderson Cancer Center
;
Seoul National University
;
Cliniques Universitaires Saint-Luc, Brussels
;
Hospital Universitari Vall d'Hebron
;
Memorial Sloan-Kettering Cancer Center
;
David Geffen School of Medicine at UCLA
;
Ohio State University
;
Universitätsklinikum Heidelberg
;
Massachusetts General Hospital Cancer Center
;
Novartis Pharmaceuticals Corporation
1-May-2018
Progress in the Management of Malignant Pleural Mesothelioma in 2017
Amanda J. McCambridge
;
Andrea Napolitano
;
Aaron S. Mansfield
;
Dean A. Fennell
;
Yoshitaka Sekido
;
Anna K. Nowak
;
Thanyanan Reungwetwattana
;
Weimin Mao
;
Harvey I. Pass
;
Michele Carbone
;
Haining Yang
;
Tobias Peikert
;
Zhejiang Cancer Hospital
;
University of Leicester
;
Università degli Studi di Roma La Sapienza
;
NYU Langone Medical Center
;
University of Western Australia
;
Aichi Cancer Center Hospital and Research Institute
;
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
;
University of Hawaii at Manoa
;
Mayo Clinic
;
Zhejiang Key Laboratory of Diagnosis and Treatment Technology of Thoracic Oncology